Metropolitan Life Insurance Company (MetLife)’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,708
Closed -$12.6K 2389
2022
Q1
$12.6K Sell
4,708
-6,734
-59% -$18K ﹤0.01% 2229
2021
Q4
$49.5K Buy
11,442
+4,796
+72% +$20.8K ﹤0.01% 2701
2021
Q3
$33.8K Sell
6,646
-12,278
-65% -$62.5K ﹤0.01% 2796
2021
Q2
$120K Buy
18,924
+2,569
+16% +$16.3K ﹤0.01% 2503
2021
Q1
$126K Buy
16,355
+11,905
+268% +$92K ﹤0.01% 2318
2020
Q4
$29.1K Sell
4,450
-9,990
-69% -$65.4K ﹤0.01% 2504
2020
Q3
$96K Sell
14,440
-194
-1% -$1.29K ﹤0.01% 2242
2020
Q2
$122K Buy
14,634
+5,858
+67% +$48.8K ﹤0.01% 2132
2020
Q1
$67.3K Sell
8,776
-3,195
-27% -$24.5K ﹤0.01% 2268
2019
Q4
$99.5K Sell
11,971
-6,711
-36% -$55.8K ﹤0.01% 2337
2019
Q3
$138K Buy
18,682
+5,098
+38% +$37.6K ﹤0.01% 2124
2019
Q2
$152K Buy
13,584
+1,575
+13% +$17.7K ﹤0.01% 2071
2019
Q1
$129K Sell
12,009
-1,470
-11% -$15.8K ﹤0.01% 2174
2018
Q4
$204K Buy
13,479
+562
+4% +$8.49K ﹤0.01% 1813
2018
Q3
$239K Hold
12,917
﹤0.01% 1886
2018
Q2
$295K Buy
12,917
+3,432
+36% +$78.5K ﹤0.01% 1678
2018
Q1
$270K Buy
9,485
+187
+2% +$5.32K ﹤0.01% 1695
2017
Q4
$196K Sell
9,298
-7,878
-46% -$166K ﹤0.01% 1920
2017
Q3
$312K Hold
17,176
﹤0.01% 2007
2017
Q2
$266K Hold
17,176
﹤0.01% 2162
2017
Q1
$297K Hold
17,176
﹤0.01% 2005
2016
Q4
$189K Hold
17,176
﹤0.01% 2379
2016
Q3
$269K Hold
17,176
﹤0.01% 2141
2016
Q2
$175K Buy
+17,176
New +$175K ﹤0.01% 2410